Compare Archi Indonesia Tbk (ARCI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Archi Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp930 (market cap 24.86T, 21.8M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 44.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 21.8M). Which is the better fit depends on your goals.
| ARCI | LABS | |
|---|---|---|
Market Cap | 24.86T | 556.95B |
Volume | 21.8M | 60.83M |
Lot | 218.04K | 608.34K |
Turnover | 20.81B | 10.26B |
Average Price | 954.51 | 168.64 |
Value | 20.81B | 10.26B |
Indicative Equilibrium Price | 930 | 152 |
Indicative Equilibrium Volume | 5.48K | 4.52K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archi Indonesia Tbk
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Read more on ARCI →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
